Q4 2022 Beyond Air Inc Earnings Call Transcript
Good afternoon, and welcome to the Beyond Air Fiscal Year 2022 Financial Results and LungFit PH Approval Conference Call. (Operator Instructions)
And now I would like to turn the call over to Corey Davis from LifeSci Advisors. Please go ahead, sir. You may begin.
Thank you, operator. Good afternoon, everyone, and thank you for joining us. Today, after market close, we issued a press release announcing FDA approval for LungFit PH and a press release announcing the company's fiscal fourth quarter and year-end 2022 operational highlights and financial results. Copies of these press releases can be found on the Investor Relations page of Beyond Air's website.
Before we begin, I'd like to remind everyone that we will be making comments and various remarks about future expectations, plans and prospects, which constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Beyond Air cautions that these
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |